Trends in antifungal use among hospitalized patients in the USA, 2018–23
Substantial antifungal use occurs among hospitalized patients, particularly among those with cancer. The growing population susceptible to fungal infections (e.g. transplants, cancer and other immunosuppressing conditions) warrants consideration of antifungal stewardship and evaluation of appropriateness of antifungal use in the context of increasing resistance.
Authors
- Teny Mathew John (ORCID: https://orcid.org/0000-0002-2675-1529)
- Dallas J. Smith (ORCID: https://orcid.org/0000-0001-5707-528X)
- Natalie J. M. Dailey Garnes
- Kaitlin Benedict (ORCID: https://orcid.org/0000-0003-0458-2493)
- Hannah R. Murphy (ORCID: https://orcid.org/0000-0001-6209-5883)
- Nancy N Vuong (ORCID: https://orcid.org/0000-0002-3053-9897)
- Alyssa Hartsell Harris (ORCID: https://orcid.org/0000-0003-2788-5817)
Institutions
- Centers for Disease Control and Prevention (US)
- The University of Texas MD Anderson Cancer Center (US)
- Vi Technology (United States) (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1093/jac/dkaf269
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40